[Protective effects of ambroxol on lung injury during cardiacpulmonary bypass in patients undergoing valve replacement].
Zhou
Hai-yang
HY
Chang
Ye-tian
YT
Lü
Zhi-ping
ZP
D000328:Adult; D000551:Ambroxol / Q000627:therapeutic use*; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D005100:Expectorants / Q000627:therapeutic use; D005260:Female; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control; D020011:Protective Agents / Q000627:therapeutic use*; D012128:Respiratory Distress Syndrome / Q000517:prevention & control*
D005100:Expectorants; D020011:Protective Agents; D000551:Ambroxol